Rice Bran Supplementation for Radiation-Induced Oral Mucositis in Head and Neck Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChristina Milad Lobos

About this trial

This study aims to find out if taking rice bran supplements can help reduce the painful mouth sores (oral mucositis) that often occur in patients with head and neck cancer who receive radiation therapy. The trial will include adult patients undergoing radiation treatment. Participants will be given rice bran supplements during their therapy to see if it can lessen these side effects and improve their overall quality of life.

Eligibility criteria

Qualifiers

Male or female patients of age 18 years old tor more

Patients with squamous cell carcinomas without metastases of other non-head and non-neck tumors.

Patients undergoing radiotherapy with an ECOG performance status of 0, 1, or 2

Patients who will receive IMRT delivered as radical or adjuvant therapy with or without concurrent chemotherapy

Disqualifiers

Receiving any other approved or investigational anti-cancer agent than those specified in this study.

Pregnant or breastfeeding female patients

Patients who have oral lesions unrelated to treatment or cancer,

Patients who are on drugs that could cause oral lesions or are using anticoagulants.

Trial design

Treatments tested in this trial

  • rice bran

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Christina Milad Lobos

Lead sponsor

German University in Cairo

Sponsor institution